Jonathan Hare | Translational Science Lead
The Francis Crick Institute

Jonathan is an accomplished R&D and global public health professional with over 15 years of expertise in translational biologics, vaccine development, and infectious disease research. Currently serving as a Translational Science Lead at the Francis Crick Institute, he plays a pivotal role in advancing research into tangible product development models, focusing on novel vaccine platforms, therapeutic antibodies, and diagnostic solutions for diseases including TB, Japanese Encephalitis, and lung cancer. Prior to this, he was Head of Immunology at Imophoron, a UK early-stage vaccine biotech company and prior to that was at IAVI, where amongst other programs he worked on developing clinical assays for their VSV-Lassa candidate. His career also includes significant consultancy work, including advising on vaccine R&D capacity in Central and West Asia and supporting early-stage vaccine companies. He is currently is a member of the WHO Technical Advisory Group on Combination Vaccines. Jonathan has a Ph.D. in Cancer Gene Immunotherapy from King’s College London and completed post-doctoral training at Louisiana State University Health Sciences Center in New Orleans and has a strong record of grant awards, publications, and multidisciplinary collaborations.